Rick Doblin
Rick Doblin
Full Name and Common Aliases
Rick Doblin is a renowned American psychologist, researcher, and advocate in the field of psychedelic research.
Birth and Death Dates
Born on August 29, 1953, to date, there is no recorded information about his passing.
Nationality and Profession(s)
Doblin is an American national with expertise in psychology, psychotherapy, and psychopharmacology. He is a licensed clinical psychologist with significant contributions to the field of psychedelic research.
Early Life and Background
Rick Doblin grew up in New York City, where he developed a deep interest in human behavior, consciousness, and the potential therapeutic applications of psychedelics. This curiosity was sparked during his teenage years when he read Aldous Huxley's "The Doors of Perception," which profoundly influenced his perspective on life.
Major Accomplishments
Doblin is best known for founding the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986. Under his leadership, MAPS has become a driving force behind psychedelic research and advocacy worldwide. Some of Doblin's notable accomplishments include:
Coordinating the first FDA-approved clinical trial on MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) in 2000
Conducting groundbreaking studies on the therapeutic potential of psychedelics like LSD, psilocybin, and MDMA
Advocating for policy reforms to allow researchers access to previously prohibited substancesNotable Works or Actions
Doblin's work has been instrumental in shaping the current landscape of psychedelic research. Some notable works include:
"The Future of Psychedelics: An Interview with Rick Doblin" (2009) - a comprehensive interview highlighting his vision for the field
"Psychedelic-Assisted Therapy: A Review of the Literature" (2018) - an in-depth review of psychedelic-assisted therapy research
His advocacy efforts have led to policy changes, such as the removal of psilocybin from Schedule I substances in several US states
Impact and Legacy
Rick Doblin's contributions have significantly impacted the field of psychedelic research, leading to a renewed interest in the therapeutic potential of psychedelics. His work has opened doors for researchers, clinicians, and policymakers, paving the way for a more comprehensive understanding of these substances.
Why They Are Widely Quoted or Remembered
Doblin is widely quoted and remembered due to his:
Pioneering work in establishing MAPS as a leading organization in psychedelic research
Advocacy efforts, which have led to policy changes and increased access to previously prohibited substances for researchers
* His commitment to exploring the therapeutic potential of psychedelics has inspired a new generation of researchers and clinicians
Quotes by Rick Doblin
Rick Doblin's insights on:
Once you’ve produced the scientific data that’s necessary to make a drug into a medicine, you’ve gone a long way towards mainstreaming the acceptance of these drugs as having beneficial properties. And then the step to legalization is not that far behind that.
We are all dying and we all have some anxiety about it. And so people are more scared of dying than they are of drugs. If we can show that people who are facing death can be assisted with psychedelics that’s a powerful message.
![Terence McKenna pointed out that "the profundity of [halluncinogenic inebriation] and its potential for a positive feedback into the process of reorganizing the personality should have long ago made psychedelics an indispensable tool for psychotherapy.](https://lakl0ama8n6qbptj.public.blob.vercel-storage.com/quotes/quote-706447.png)
Terence McKenna pointed out that "the profundity of [halluncinogenic inebriation] and its potential for a positive feedback into the process of reorganizing the personality should have long ago made psychedelics an indispensable tool for psychotherapy.
The cultural integration of psychedelics won't happen overnight, and the question of young people is perhaps the most difficult involved. The first step is for people who have knowledge of these substances to share it, "coming out" about their own experiences. Drug education should be honest and present a balanced picture of risks and benefits.
Psychedelics are not a substitute for faith. They are a door to authentic faith, born of encountering directly the sacred dimension of everyday experience. This is not the only gate to that discovery, but it is the most ancient and universal, and potentially the most accessible to the majority of the human race.
People tend to link "sex and drugs" because both are condemned by society. Nevertheless, throughout the ages human beings have continually searched for more ecstasy, more sexual satisfaction, for solutions to their sexual problems, and for aphrodisiacs.
The human psyche is not unitary; we all have different parts. This phenomenon is widely recognized, but in psychiatry the terminology and theories about it are far from unified. Nevertheless, I think dissociation, parts, sub-personalities, selves, and complexes are all referring to the same or to overlapping phenomenon.
It should come as no surprise to readers of the MAPS Bulletin that psychedelic plants are used as a sacrament by many native cultures all over the world. It may not be so obvious that these same plants are often incorporated into the coming-of-age ceremonies of these various societies.
The question that we need to address is this: What relevance do these ancient traditions have to the experience of a modern adolescent growing up in the Western world? Rather than indulge in idle speculation, I have invited a number of young people to express their views on psychedelics and the effects these substances have had upon their lives and minds.
My brief survey of stimulant aphrodisiacs would be incomplete were I to fail to include that most famous love drug of all time, chocolate or cacao, from the seeds of Theobroma cacao.